Surgical Innovations Group plc

LSE:SUN UK Medical Devices
Market Cap
$51.07K
GBX419.77 Million GBX
Market Cap Rank
#48875 Global
#1250 in UK
Share Price
GBX0.45
Change (1 day)
+0.00%
52-Week Range
GBX0.45 - GBX0.70
All Time High
GBX4.63
Categories
Companies in UK Medical Devices
About

Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. The company operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. It o… Read more

Surgical Innovations Group plc (SUN) - Net Assets

Latest net assets as of June 2025: GBX8.56 Million GBX

Based on the latest financial reports, Surgical Innovations Group plc (SUN) has net assets worth GBX8.56 Million GBX as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX11.50 Million) and total liabilities (GBX2.94 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX8.56 Million
% of Total Assets 74.45%
Annual Growth Rate 5.64%
5-Year Change -22.98%
10-Year Change 117.33%
Growth Volatility 115.85

Surgical Innovations Group plc - Net Assets Trend (1989–2024)

This chart illustrates how Surgical Innovations Group plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Surgical Innovations Group plc (1989–2024)

The table below shows the annual net assets of Surgical Innovations Group plc from 1989 to 2024.

Year Net Assets Change
2024-12-31 GBX8.54 Million -18.53%
2023-12-31 GBX10.48 Million -4.37%
2022-12-31 GBX10.96 Million +2.80%
2021-12-31 GBX10.66 Million -3.84%
2020-12-31 GBX11.09 Million -9.04%
2019-12-31 GBX12.19 Million -15.47%
2018-12-31 GBX14.42 Million +5.15%
2017-12-31 GBX13.72 Million +134.94%
2016-12-31 GBX5.84 Million +48.55%
2015-12-31 GBX3.93 Million -35.77%
2014-12-31 GBX6.12 Million -57.84%
2013-12-31 GBX14.52 Million +7.02%
2012-12-31 GBX13.56 Million +7.51%
2011-12-31 GBX12.62 Million +19.15%
2010-12-31 GBX10.59 Million +22.55%
2009-12-31 GBX8.64 Million +7.46%
2008-12-31 GBX8.04 Million +8.50%
2007-12-31 GBX7.41 Million +164.74%
2006-12-31 GBX2.80 Million +33.67%
2005-12-31 GBX2.09 Million +26.91%
2004-12-31 GBX1.65 Million +18.28%
2003-12-31 GBX1.40 Million +11.78%
2002-12-31 GBX1.25 Million +9.38%
2001-12-31 GBX1.14 Million +8.05%
2000-12-31 GBX1.06 Million +238.58%
1999-12-31 GBX-762.00K -1020.59%
1998-12-31 GBX-68.00K -107.00%
1997-12-31 GBX972.00K +383.58%
1996-08-31 GBX201.00K -83.26%
1995-08-31 GBX1.20 Million -56.39%
1994-08-31 GBX2.75 Million -48.22%
1993-08-31 GBX5.32 Million +288.53%
1992-08-31 GBX1.37 Million -18.61%
1991-08-31 GBX1.68 Million +402.09%
1990-08-31 GBX335.00K -72.74%
1989-08-31 GBX1.23 Million --

Equity Component Analysis

This analysis shows how different components contribute to Surgical Innovations Group plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 872800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock GBX9.33 Million 109.21%
Other Components GBX8.17 Million 95.61%
Total Equity GBX8.54 Million 100.00%

Surgical Innovations Group plc Competitors by Market Cap

The table below lists competitors of Surgical Innovations Group plc ranked by their market capitalization.

Company Market Cap
FSTU11F
SA:FSTU11F
 		$511.26
ETAO International Co., Ltd.
PINK:ETAOF
 		$511.79
MURRAY & ROB HLDGS (LDYA.SG)
STU:LDYA
 		$511.94
Fauji Foods Ltd
KAR:FFL
 		$514.78
Wellnex Life Limited
LSE:WNX
 		$510.69
Empyrean Energy Plc
LSE:EME
 		$509.41
Bay Capital PLC
LSE:BAY
 		$508.89
Vox Valor Capital Ltd.
LSE:VOX
 		$508.55

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Surgical Innovations Group plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 10,484,000 to 8,541,000, a change of -1,943,000 (-18.5%).
  • Net loss of 1,943,000 reduced equity.
  • Other comprehensive income decreased equity by 329,000.
  • Other factors increased equity by 329,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income GBX-1.94 Million -22.75%
Other Comprehensive Income GBX-329.00K -3.85%
Other Changes GBX329.00K +3.85%
Total Change GBX- -18.53%

Book Value vs Market Value Analysis

This analysis compares Surgical Innovations Group plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 49.15x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 13.06x to 49.15x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1989-08-31 GBX0.03 GBX0.45 x
1990-08-31 GBX0.01 GBX0.45 x
1991-08-31 GBX0.04 GBX0.45 x
1992-08-31 GBX0.03 GBX0.45 x
1993-08-31 GBX0.13 GBX0.45 x
1994-08-31 GBX0.07 GBX0.45 x
1995-08-31 GBX0.03 GBX0.45 x
1996-08-31 GBX0.00 GBX0.45 x
1998-12-31 GBX0.00 GBX0.45 x
1999-12-31 GBX0.00 GBX0.45 x
2000-12-31 GBX0.00 GBX0.45 x
2001-12-31 GBX0.00 GBX0.45 x
2002-12-31 GBX0.00 GBX0.45 x
2003-12-31 GBX0.01 GBX0.45 x
2004-12-31 GBX0.01 GBX0.45 x
2005-12-31 GBX0.01 GBX0.45 x
2006-12-31 GBX0.01 GBX0.45 x
2007-12-31 GBX0.02 GBX0.45 x
2008-12-31 GBX0.02 GBX0.45 x
2009-12-31 GBX0.02 GBX0.45 x
2010-12-31 GBX0.03 GBX0.45 x
2011-12-31 GBX0.03 GBX0.45 x
2012-12-31 GBX0.03 GBX0.45 x
2013-12-31 GBX0.04 GBX0.45 x
2014-12-31 GBX0.01 GBX0.45 x
2015-12-31 GBX0.01 GBX0.45 x
2016-12-31 GBX0.01 GBX0.45 x
2017-12-31 GBX0.02 GBX0.45 x
2018-12-31 GBX0.02 GBX0.45 x
2019-12-31 GBX0.02 GBX0.45 x
2020-12-31 GBX0.01 GBX0.45 x
2021-12-31 GBX0.01 GBX0.45 x
2022-12-31 GBX0.01 GBX0.45 x
2023-12-31 GBX0.01 GBX0.45 x
2024-12-31 GBX0.01 GBX0.45 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Surgical Innovations Group plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -22.75%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -16.27%
  • • Asset Turnover: 0.98x
  • • Equity Multiplier: 1.43x
  • Recent ROE (-22.75%) is above the historical average (-45.30%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1989 -18.31% -340.91% 0.03x 1.84x GBX-347.90K
1990 -266.57% -276.47% 0.24x 4.09x GBX-926.50K
1991 -104.16% -593.90% 0.10x 1.81x GBX-1.92 Million
1992 -123.23% -249.56% 0.24x 2.08x GBX-1.82 Million
1993 -40.01% -189.32% 0.17x 1.25x GBX-2.66 Million
1994 -85.48% -1110.38% 0.05x 1.44x GBX-2.63 Million
1995 -209.41% -391.74% 0.26x 2.07x GBX-2.64 Million
1996 -613.93% -266.52% 0.65x 3.55x GBX-1.25 Million
1998 0.00% -64.23% 0.71x 0.00x GBX-1.07 Million
1999 0.00% -55.30% 0.70x 0.00x GBX-617.80K
2000 -5.40% -3.18% 1.07x 1.59x GBX-162.60K
2001 7.36% 4.55% 1.01x 1.60x GBX-30.10K
2002 6.25% 3.51% 0.96x 1.85x GBX-46.80K
2003 9.96% 5.05% 0.96x 2.05x GBX-500.00
2004 12.85% 6.99% 1.04x 1.76x GBX47.00K
2005 19.20% 10.00% 1.28x 1.50x GBX192.60K
2006 24.87% 15.61% 1.14x 1.40x GBX416.10K
2007 10.32% 16.04% 0.51x 1.26x GBX24.00K
2008 7.84% 14.61% 0.39x 1.38x GBX-174.00K
2009 6.08% 11.56% 0.39x 1.34x GBX-339.00K
2010 16.89% 25.38% 0.52x 1.28x GBX729.20K
2011 13.78% 22.86% 0.40x 1.50x GBX476.40K
2012 5.06% 8.98% 0.42x 1.35x GBX-670.30K
2013 5.51% 9.35% 0.41x 1.42x GBX-651.50K
2014 -154.55% -234.72% 0.36x 1.84x GBX-10.07 Million
2015 -51.73% -37.18% 0.70x 1.98x GBX-2.43 Million
2016 12.26% 11.76% 0.89x 1.17x GBX132.20K
2017 4.56% 7.15% 0.47x 1.35x GBX-745.60K
2018 5.03% 6.61% 0.58x 1.31x GBX-717.30K
2019 -21.48% -24.40% 0.66x 1.34x GBX-3.84 Million
2020 -29.54% -51.76% 0.39x 1.47x GBX-4.38 Million
2021 -4.28% -5.00% 0.58x 1.47x GBX-1.52 Million
2022 2.41% 2.33% 0.73x 1.42x GBX-832.30K
2023 -4.86% -4.24% 0.84x 1.37x GBX-1.56 Million
2024 -22.75% -16.27% 0.98x 1.43x GBX-2.80 Million

Industry Comparison

This section compares Surgical Innovations Group plc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $79,119,479
  • Average return on equity (ROE) among peers: -17.62%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Surgical Innovations Group plc (SUN) GBX8.56 Million -18.31% 0.34x $510.74
AOTI Inc (AOTI) $3.41 Million 51.02% 1.74x $5.95K
Belluscura Plc (BELL) $1.20 Million -81.38% 0.34x $366.21
Creo Medical Group PLC (CREO) $59.80 Million -36.29% 0.28x $8.34K
Inspiration Healthcare Group PLC (IHC) $28.97 Million -20.83% 0.69x $2.87K
Intelligent Ultrasound Group PLC (IUG) $12.16 Million -24.53% 0.32x $5.19K
NIOX Group PLC (NIOX) $440.90 Million -11.32% 0.11x $31.53K
Rua Life Sciences PLC (RUA) $7.39 Million 0.01% 0.25x $1.01K